George Llado is Senior Vice President, Integration and Innovation at AstraZeneca, responsible for the Alexion Pharmaceuticals integration and rapid technology innovation acceleration cycles across AstraZeneca. Previously, George was the Chief Information Officer of Alexion Pharmaceuticals, responsible for building the company’s Global Information Technology function that enabled Alexion to serve patients and their families with rare diseases through the innovation, development, and commercialization of life-changing therapies.
A bio-pharma industry veteran with more than 34 years of business, information technology, and cyber-security experience, George and his team develop and implement innovative technology and enable data-driven insights across Alexion’s R&D, Commercial, Manufacturing Operations, and Supply Chain functions.
Prior to joining Alexion, George served as Vice President and business line CIO for Merck and Co., where he led the large-scale merger integration of Merck/Schering-Plough across the IT and Shared Business Services organizations. George previously worked at Citibank, N.A.
George serves on the Board of Directors of Charles River Laboratories and the National Center for Women & Information Technology (NCWIT). He also serves on the Advisory Board of Sierra Ventures and Temple University’s Fox Business School. George holds a Bachelor of Science in Computer Science from New York Institute of Technology and completed the Executive Development Program at both Harvard and the Wharton School of Business.
George was named to the Forbes CIO Next 2021 list, which highlights top tech executives who are redefining the CIO role and driving game-changing innovation. In 2020, he was named a Global CIO of the Year finalist by the Boston CIO Leadership Association for demonstrating excellence in technology leadership.
